ÌÇÐÄÆƽâ°æ

Number of FDA approvals for new molecular entities in the periods 1999-2001 and 2009-2011

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2013

Region

United States

Survey time period

1999 to 2011

Supplementary notes

FDA = U.S. Food and Drug Administration.

Citation formats

Number of FDA approvals for new molecular entities in 1999-2001 and 2009-2011

Published by ÌÇÐÄÆƽâ°æ Research Department, Jul 23, 2013
This statistic depicts the number of FDA approvals for new molecular entities in the periods 1999-2001 and 2009-2011. In the United States, the number of approvals in dermatology and respiratory areas both dropped from approvals in 1999-2001 to just *** in 2009-2011.
Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

10

Other regions

10

Related statistics

10

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in RomaniaSanofiBiotech drugs worldwideBiotechnology in SpainPfizer
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.